About
Nebu~Flow is a start-up medical device company focused on developing advanced nebuliser technology for efficient pulmonary drug delivery. Their core innovation utilizes acoustic waves to create aerosols with droplet sizes smaller than 5 micrometres, which enhances the delivery of a variety of therapeutics, including challenging biologics and gene therapies. The user-friendly, breath-actuated nebulisers are designed to improve clinical outcomes and reduce treatment times. Founded in 2019 and operating under Acu-Flow Limited, Nebu~Flow has a team with over 150 years of combined experience in respiratory drug delivery. The company has received recognition for its innovative approach, winning awards such as the CPHI 2024 Start-up Initiative and the Institute of Physics Business Start-Up Award. Nebu~Flow aims to collaborate with pharmaceutical partners to co-develop drug-device combinations, targeting serious respiratory conditions like cystic fibrosis and COPD, and addressing the global burden of respiratory diseases.
Technologies
Keywords
Company Information
-
Employees 17
-
Founded 2019
-
Annual Revenue $2111000
-
Total Funding $7994077
Location
19 Waterloo Street, Glasgow, Scotland, United Kingdom, G2 6AY